ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Heterogeneity of genomic profile in patients with HER2-positive breast cancer

Bo Chen; Zhang, Guochun; Wei, Guangnan; Wang, Yulei; Guo, Liping; Lin, Jiali; Kai Li; Mok, Hsiaopei; Li Cao; Ren, Chongyang; Wen, Lingzhu; Jia, Minghan; Li, Cheukfai; Ting Hou; Han Han-Zhang; Jing Liu; Balch, Charles M.; Ning Liao*广东省人民医院; 南方医科大学
Endocrine-Related Cancer2020-3DOI: 10.1530/ERC-19-0414
22被引5阅读
引用收藏
分享

摘要

HER2-positive breast cancer is a biologically and clinically heterogeneous disease. Based on the expression of hormone receptors (HR), breast tumors can be further categorized into HR positive and HR negative. Here, we elucidated the comprehensive somatic mutation profile of HR+ and HR- HER2-positive breast tumors to understand their molecular heterogeneity. In this study, 64 HR+/HER2+ and 43 HR-/HER2+ stage I-Ill breast cancer patients were included. Capture-based targeted sequencing was performed using panel consisting of 520 cancer-related genes, spanning 1.64 megabases of the human genome. A total of 1119 mutations were detected among the 107 HER2-positive patients. TP53, CDK12 and PIK3CA were the most frequently mutated, with mutation rates of 76, 61 and 49, respectively. HR+/HER2+ tumors had more gene amplification, splice site and frameshift mutations and a smaller number of missense, nonsense and insertion-deletion mutations than HR-/HER2+ tumors. In KEGG analysis, HR+/HER2+ tumors had more mutations in genes involved in homologous recombination (P = 0.004), TGF-beta (P = 0.007) and WNT (P = 0.002) signaling pathways than HR-/HER2+ tumors. Moreover, comparative analysis of our cohort with datasets from The Cancer Genome Atlas and Molecular Taxonomy of Breast Cancer International Consortium revealed the distinct somatic mutation profile of Chinese HER2-positive breast cancer patients. Our study revealed the heterogeneity of somatic mutations between HR+/HER2+ and HR-/HER2+ in Chinese breast cancer patients. The distinct mutation profile and related pathways are potentially relevant in the development of optimal treatment strategies for this subset of patients.

学科与关键词

关键词
HER2-positive breast cancerChinese breast cancerhormone receptormutation landscapeERBB family
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Endocrine-Related Cancer
发表日期
2020-03
卷期
第 27 卷, 第 3 期
页码
153-162
DOI
10.1530/ERC-19-0414
语言
ENGLISH
期刊收录
NSL.SCIE
期刊等级
2区
成果收录
SCIE
资助标注
High-level Hospital Construction Project [DFJH201921]; Natural Science Foundation of Guangdong Province [2016A030313768, 2018A030313292]; Guangzhou Municipal Science and Technology Project [201707010418, 201804010430]; National Natural Science Foundation of China [81902828, 81602645]; Fundamental Research Funds for the Central Universities [y2syD2192230]; Medical Scientific Research Foundation of Guangdong Province [B2019039]

作者

  • B

    Bo Chen (第一作者)

    guangdong prov peoples hosp

  • Z

    Zhang, Guochun

    guangdong prov peoples hosp

查看全部 18 位作者收起作者
  • W

    Wei, Guangnan

    guangdong prov peoples hosp

  • W

    Wang, Yulei

    guangdong prov peoples hosp

  • G

    Guo, Liping

    2 · southern med univ · guangdong prov peoples hosp

  • L

    Lin, Jiali

    2 · southern med univ · guangdong prov peoples hosp

  • K

    Kai Li

    guangdong prov peoples hosp

  • M

    Mok, Hsiaopei

    guangdong prov peoples hosp

  • L

    Li Cao

    guangdong prov peoples hosp

  • R

    Ren, Chongyang

    guangdong prov peoples hosp

  • W

    Wen, Lingzhu

    guangdong prov peoples hosp

  • J

    Jia, Minghan

    guangdong prov peoples hosp

  • L

    Li, Cheukfai

    guangdong prov peoples hosp

  • T

    Ting Hou

  • H

    Han Han-Zhang

  • J

    Jing Liu

  • B

    Balch, Charles M.

  • N

    Ning Liao (通讯)

    guangdong prov peoples hosp

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417